Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

At the european society of gene and cell therapy 27th annual congress, Axovant presents first evidence of clinical stabilization in tay-sachs disease. Read Press Release

Login